OptimizeRx (OPRX) Total Debt (2019 - 2026)

OptimizeRx's Total Debt history runs 6 years deep, the most recent figure standing at $23.3 million for Q1 2026.

• In Q1 2026, Total Debt fell 28.15% year-over-year to $23.3 million; the TTM figure through Mar 2026 stood at $23.3 million (down 28.15% YoY), while the FY2025 annual figure was $25.7 million, down 21.76% from the prior year.
• Total Debt came in at $23.3 million for Q1 2026 at OptimizeRx, down from $25.7 million in the prior quarter.
• In the past five years, Total Debt ranged from a high of $36.2 million in Q4 2023 to a low of $23.3 million in Q1 2026.
• A 4-year average of $31.4 million and a median of $32.7 million in 2024 frame the typical range for Total Debt.
• Across the five-year window, Total Debt slipped 9.43% in 2024 and fell 28.15% in 2026, its largest moves.
• OptimizeRx's Total Debt stood at $36.2 million in 2023, then retreated by 9.43% to $32.8 million in 2024, then declined by 21.76% to $25.7 million in 2025, then fell by 9.09% to $23.3 million in 2026.
• According to Business Quant data, Total Debt over the past three periods registered $23.3 million, $25.7 million, and $28.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison